Maintaining Innovation and Safe Technologies Act

The Maintaining Innovation and Safe Technologies Act requires the U.S. Department of Health and Human Services to issue Medicare Part B payment guidance by January 1, 2027, for remote monitoring devices that use artificial intelligence. This guidance will clarify payment rules for devices like continuous glucose monitors, which must have an AI component (e.g., automatic adjustments) and transmit patient data to healthcare providers for treatment management. The bill directly affects Medicare coverage for these AI-enabled medical devices, used by patients managing chronic conditions such as diabetes. It does not change current reimbursement rates but mandates clear payment criteria through updated guidance by the specified deadline.